Journal Pre-proof Effects of midfoot joint mobilization on ankle-foot morphology and function following acute ankle sprain. A crossover clinical trial John J. Fraser, Susan A. Saliba, Joseph M. Hart, Joseph S. Park, Jay Hertel PII:
S2468-7812(19)30149-3
DOI:
https://doi.org/10.1016/j.msksp.2020.102130
Reference:
MSKSP 102130
To appear in:
Musculoskeletal Science and Practice
Received Date: 2 May 2019 Revised Date:
23 January 2020
Accepted Date: 4 February 2020
Please cite this article as: Fraser, J.J., Saliba, S.A., Hart, J.M., Park, J.S., Hertel, J., Effects of midfoot joint mobilization on ankle-foot morphology and function following acute ankle sprain. A crossover clinical trial, Musculoskeletal Science and Practice (2020), doi: https://doi.org/10.1016/ j.msksp.2020.102130. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Ltd.
Title: Effects of midfoot joint mobilization on ankle-foot morphology and function following acute ankle sprain. A crossover clinical trial.
Authors: John J. Fraser, PT, DPT, PhD1, 2 Susan A. Saliba, PT, PhD, ATC1 Joseph M. Hart, PhD, ATC1 Joseph S. Park, MD3 Jay Hertel, PhD, ATC 1
Affiliations: 1. Department of Kinesiology, University of Virginia, 210 Emmet Street South, Charlottesville, VA 22904-4407, USA; 2. Warfighter Performance Department, Naval Health Research Center, USA 3. Department of Orthopaedic Surgery, University of Virginia, Charlottesville, VA, USA
Conflicts of Interest: I affirm that I have no financial affiliation or involvement with any commercial, organization that has a direct financial interest in any matter included in this manuscript.
Disclosures: This study was funded in part by the University of Virginia’s Curry School of Education Foundation and the Navy Medicine Professional Development Center. The views expressed in this manuscript reflect the results of research conducted by the author(s) and do not necessarily reflect the official policy or position of the Department of the Navy, Department of
Defense, nor the U.S. Government. Lieutenant Commander John J. Fraser is a military service member and this work was prepared as part of his official duties. Title 17, USC, §105 provides that ‘Copyright protection under this title is not available for any work of the U.S. Government.’ Title 17, USC, §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties. All participants provided informed consent and this study was approved by the Institutional Review Board for Health Sciences Research at the University of Virginia in compliance with all applicable Federal regulations governing the protection of human subjects. This work was performed in partial fulfillment of the requirement for the doctor of philosophy degree and is archived in the Online Archive of University of Virginia Scholarship (DOI: 10.18130/V3GN1K).
Presented at the Combined Sections Meeting of the American Physical Therapy Association, 23 February 2018, New Orleans, LA and is archived at DOI: 10.7490/f1000research.1115281.1.
Acknowledgements: Rachel Koldenhoven, MEd, ATC and Abbis H. Jaffri, PT, MS for their assistance in performing the clinical examinations. Stephan Bodkin, MEd, ATC for his assistance with allocation. Navy Medicine Professional Development Center and the University of Virginia’s Curry School of Education Foundation for their generosity in providing funding.
Corresponding Author: John J Fraser, Warfighter Performance Department, Naval Health Research Center, 140 Sylvester Road, San Diego, CA 92106 Phone: 757-438-0390 Email:
[email protected] ORCID: 0000-0001-9697-3795 Twitter: @NavyPT
Key Words: Ankle Injuries; Recovery of Function; Musculoskeletal Manipulations; Pain Perception; Therapeutics; Treatment Outcome
Title: Effects of midfoot joint mobilization on ankle-foot morphology and function following acute ankle sprain. A crossover clinical trial.
Conflicts of Interest: I affirm that I have no financial affiliation or involvement with any commercial, organization that has a direct financial interest in any matter included in this manuscript.
1
Abstract
2
Background: Midfoot joint impairment is likely following lateral ankle sprain (LAS) that may
3
benefit from mobilization.
4
Objective: To investigate the effects of midfoot joint mobilizations and a one-week home
5
exercise program (HEP) compared to a sham intervention and HEP on pain, patient-reported
6
outcomes (PROs), ankle-foot joint mobility, and neuromotor function in young adults with recent
7
LAS.
8
Methods: All participants were instructed in a stretching, strengthening, and balance HEP and
9
were randomized a priori to receive midfoot joint mobilizations (forefoot supination, cuboid
10
glide and plantar 1st tarsometatarsal) or a sham laying-of-hands. Changes in pain, physical,
11
psychological, and functional PROs, foot morphology, joint mobility, pain-to-palpation,
12
neuromotor function, and dynamic balance were assessed pre-to-post treatment and one-week
13
following. Participants crossed-over following a one-week washout to receive the alternate
14
treatment and were assessed pre-to-post treatment and one-week following. ANOVAs, t-tests,
15
proportions, and 95% confidence intervals (CI) were calculated to assess changes in outcomes.
16
Cohen’s d and 95% CI compared treatment effects at each time-point.
17
Results: Midfoot joint mobilization had greater effects (p<.05) in reducing pain 1-week post
18
(d=0.8), and increasing Single Assessment Numeric Evaluation (immediate: d =0.6) and Global
19
Rating of Change (immediate: d =0.6) compared to a sham treatment and HEP.
20
Conclusion: Midfoot joint mobilizations and HEP yielded greater pain reduction and perceived
21
improvement compared to sham and is recommended in a comprehensive rehabilitation program
22
following LAS.
23
Level of Evidence: II
24 25
Key Words: Ankle Injuries; Recovery of Function; Musculoskeletal Manipulations; Pain
26
Perception; Therapeutics; Treatment Outcome
27 28
Word Count: 3678
29
INTRODUCTION
30 31
Lateral ankle sprains (LAS) are common musculoskeletal injuries incurred by athletes6,46
32
and the general public.49 LAS involve high-velocities and extremes of rearfoot inversion and
33
tibial external rotation32,43 that result in injury of the lateral talocrural18,26 and midfoot1,25,47
34
ligaments. Forty-percent of LAS will progress to chronic ankle instability (CAI),11 a clinical
35
condition described by perceived or episodic ankle giving-way, persistent activity limitation, and
36
participation restriction that persist beyond one-year post injury.10
37
Midfoot injury is common following LAS and may contribute to patient signs and
38
symptoms.13 Of patients who incurred LAS, 21-41% had midfoot ligamentous involvement1,47
39
and 33% had midfoot joint capsular injury.47 Approximately one-quarter of individuals with
40
isolated calcaneocuboid ligament injury were initially diagnosed as having a LAS.1 Midfoot
41
injury may contribute to or mimic LAS symptoms.13 Similar to LAS, persistent pain, swelling,
42
giving-way, and repeat episodes of injury are potential consequences following midfoot injury.47
43
Cuboid Syndrome, a disrupted congruency of the calcaneocuboid joint, is another potential
44
consequence following LAS.5 This syndrome is theorized to result from rearfoot inversion with
45
the forefoot loaded (relative forefoot eversion),5 or an eversion moment of the cuboid during a
46
forceful fibularis longus contraction during LAS.40 Joint mobility assessment of all segments of
47
the ankle-foot complex, especially the midfoot and forefoot, has been recommended for all LAS
48
patients regardless of symptom presentation.13,15
49
In a recent cross-sectional study of ankle-foot morphology and function comparing young
50
adults with and without a history of LAS and CAI, the LAS group with a 2-8 week chronicity
51
demonstrated increased forefoot eversion and tarsometatarsal motion and no differences in total
52
joint excursion compared to healthy controls.15 Diminished forefoot inversion and 1st
53
tarsometarsal plantar joint play measures were also observed.15 These findings were postulated to
54
result from a shift in relative motion further into eversion,15 consistent with the mechanism
55
thought to cause Cuboid Syndrome.5
56
Joint mobilization, stretching, and strengthening exercises have been suggested for
57
patients with midfoot joint impairment.13,15,40 However, evidence for midfoot joint mobilization
58
and exercise following LAS is limited.28,40 Therefore, the purpose of this crossover clinical trial
59
was to investigate the effects of midfoot joint mobilization and a one-week home exercise
60
program (HEP) compared to a sham intervention and HEP on patient-reported and clinical
61
measures in young adults with recent history of LAS.
62 63 64 65
METHODS DESIGN A laboratory-based, crossover clinical trial was performed where the independent
66
variable was treatment (50% allocated to initially receive joint mobilization, 50% allocated to
67
initially receive sham). The primary dependent variables were changes in patient-reported pain
68
and function, foot morphology (foot mobility magnitude, arch height flexibility), joint motion
69
(weight-bearing dorsiflexion, rearfoot goniometry, forefoot inclinometry, 1st metatarsal
70
displacement), strength (handheld dynamometry), and dynamic balance (Star Excursion Balance
71
Test, SEBT) immediately post-treatment and one-week following. Crossover design was selected
72
over a parallel randomized control trial to ensure the individual factors of joint phenotype, injury
73
heterogeneity, and psychological factors4 were accounted for in the design. Controlling these
74
factors superseded the risk of carryover effects or the natural healing that may have occurred
75
during the two-week study period. The trial was registered with the National Institutes of Health
76
(NCT02697461). The study was approved by the university’s Institutional Review Board.
77 78 79
PARTICIPANTS A convenience sample of 17 recreationally-active individuals (8 males, 9 females) aged
80
18-35 with a recent history of LAS were recruited at a public university. Recreationally-active
81
was defined as participation in some form of physical activity for at least 20-minutes per day, at
82
least three times a week. Participants who sustained LAS in the past 2-8 weeks and presented
83
with forefoot-on-rearfoot hypomobility13 were included. Participant demographics and self-
84
report measures are in Table 1. Individuals were excluded if they had a self-reported history of
85
leg or foot fracture, neurological or vestibular impairment that affected balance, diabetes
86
mellitus, lumbosacral radiculopathy, soft tissue disorders such as Marfan or Ehlers-Danlos
87
syndrome, any absolute contraindication to manual therapy, or if they were pregnant.
88
Participants who met inclusion criteria provided informed consent. Figure 1 details the
89
CONSORT39 flow chart from recruitment to analysis.
90
PROCEDURES
91
Baseline Visit
92
Participants provided demographic information, health and injury history, and completed
93
the Foot and Ankle Ability Measure (FAAM) ADL36 and Sport subscales,7 Identification of
94
Functional Ankle Instability (IdFAI),12 the Patient Reported Outcomes Measurement Information
95
System (PROMIS) General Health Questionnaire,22 the 11-item Tampa Scale of Kinesiophobia
96
(TSK-11),50 and the Godin Leisure-time Exercise Questionnaire.17 Height, mass, and leg length
97
were measured. Foot posture was assessed in standing using the Foot Posture Index–6 item
98
version (FPI), a categorical measure of foot type that is based on five observations and one
99
palpatory assessment.44
100
Demographic, medical history, and FPI assessments were performed by a physical
101
therapist and board-certified orthopaedic clinical specialist with 15-years of clinical experience.
102
Physical examinations were performed by either an athletic trainer with three-years clinical
103
experience or a physical therapist with two-years clinical experience who were blinded to
104
participants’ medical history, functional status, and treatment allocation.
105
Morphologic Foot Assessment
106
Morphologic foot measurements were obtained using the Arch Height Index
107
Measurement System (JAKTOOL Corporation, Cranberry, NJ). Total and truncated foot length,
108
arch height, and foot width were measured in sitting and standing. Test-retest reliability for these
109
measures were previously reported by the authors to be excellent.16 Arch height flexibility51 and
110
foot mobility magnitude38 were calculated using the component measurements across loading
111
conditions.
112
Ligamentous Pain-to-Palpation
113
A digital palpatory examination of the anterior talofibular (ATFL), calcaneofibular, and
114
bifurcate ligaments was performed. Participants reported the presence or absence of pain.
115
Joint Motion Measures
116
Weight bearing dorsiflexion (WBDF)3, ankle plantarflexion, inversion, and eversion, and
117
forefoot inversion and eversion joint motion measures16 were performed using previously
118
described methods. WBDF was reported as the linear distance measured from the wall to the toes
119
in centimeters. Joint motion measures of rearfoot plantarflexion, inversion, and eversion were
120
performed using a 30.5-cm plastic goniometer (Merck Corporation, Kenilworth, NJ) and
121
reported in degrees. Forefoot inversion and eversion was measured using a digital inclinometer
122
(Fabrication Enterprises, White Plains, NY) and reported in degrees. Linear excursion of first
123
metatarsal (MT) dorsiflexion and plantarflexion were measured utilizing a custom measuring
124
device consisting of two metal rulers bent to 90° and reported in millimeters.19 Test-retest
125
reliability for these measures were previously reported by the authors to be good to excellent.16,19
126
Muscle Strength
127
Ankle dorsiflexion, plantarflexion, inversion, eversion, and hallux flexion and lesser toe
128
flexion strength were assessed with a handheld dynamometer (Hoggan Health Industries, West
129
Jordan, UT).16 For toe flexion strength measures, the ankle was positioned in 45º plantarflexion
130
to reduce contribution of the extrinsic foot muscles and increase demand of the intrinsic foot
131
muscles.21 Strength measures were based on the highest value of three trials. An estimate of
132
torque was derived from the product of force and segment length, normalized to body mass, and
133
reported in Nmkg-1. Test-retest reliability for these measures were previously reported by the
134
authors to be excellent.16
135
Dynamic Balance
136
Dynamic balance was assessed using the anterior, posteromedial, and posterolateral
137
directions of the Star Excursion Balance Test (SEBT),23 a measure has been found to have
138
excellent test-retest reliability.30 Reach distance was normalized to leg length.20 A composite
139
measurement was calculated from the mean of the three directions.
140
Intervention
141
Following baseline assessment, all participants were instructed in a HEP consisting of
142
triceps surae stretching; four-way stretch of the rearfoot, midfoot, and forefoot; isotonic
143
inversion, eversion and dorsiflexion exercises against resistance tubing; single-limb heel raising;
144
and a single limb balance exercise (Figure 2).14 Participants were asked to perform all exercises
145
three times daily, were provided a handout detailing the exercises, and verbalized understanding
146
following instruction. The decision to utilize a HEP over supervised rehabilitation was to better
147
elucidate the specific treatment effects of the midfoot joint mobilizations.
148
Participants were randomized a priori using a random number generator by the senior
149
author and stratified by sex to receive either the midfoot joint mobilizations or sham intervention
150
on the initial visit. Allocation was performed by an otherwise uninvolved laboratory assistant,
151
concealed in a sealed opaque envelope, and opened by the treating clinician. Participants
152
allocated to receive midfoot mobilizations were provided a dorsolateral cuboid glide with
153
forefoot supination and 1st tarsometatarsal plantar glides.13 Each mobilization technique was an
154
oscillatory Maitland Grade IV applied for 30-seconds duration. If cavitation was not experienced
155
during the first bout of oscillations, a second 30-second bout was provided. Participants allocated
156
to the sham treatment were told that they were to receive a gentle soft-tissue technique similar to
157
massage and were provided a “laying of hands” for 30-seconds using the same hand position and
158
contacts used for the joint mobilizations. Participants rated the change of symptoms using a
159
single assessment numeric evaluation (SANE, -100%=full exacerbation, 0=no change,
160
100%=full resolution) immediately post-intervention and completed the Global Rating of
161
Change (GROC, -7= A very great deal worse, 0= About the same, 7= A very great deal better).
162
Follow-up Visit
163
Participants returned to the laboratory following a one-week washout for reassessment.
164
They completed the PROMIS, Godin, FAAM-ADL and Sport, SANE, and GROC. HEP
165
compliance was assessed by having the participants demonstrate the instructed exercises.
166
Participants were rated by the treating clinician whether or not they could demonstrate the
167
exercises without hesitation and with appropriate technique. Participants rated their compliance
168
using a SANE, with 0% reflective of complete non-compliance with all home exercises and
169
100% representing performance of all exercises three times daily. Any deficiencies in exercise
170
technique were corrected and participants were provided encouragement to continue.
171
Repeat physical examinations were performed pre-and post-intervention. Following the
172
pre-intervention physical examination, participants crossed over to receive the second
173
intervention (i.e. individuals who initially received the sham intervention now received the
174
midfoot joint mobilizations). Participants rated treatment response (SANE) immediately post-
175
intervention and at the end of the visit and completed the GROC.
176
Final Visit
177
Participants returned to the laboratory one-week later for the final reassessment visit
178
consisting of HEP compliance, patient-reported outcomes, and physical examination.
179
STATISTICAL ANALYSIS
180
A priori sample size estimation of 14 participants were needed based on an anticipated 15-
181
point change in the FAAM Sport, an =.05, and =.20.24 Descriptive statistics were calculated for
182
demographic and self-reported measures for each subset of the sample allocated to receive either
183
sham or midfoot mobilization during the first visit. Independent t-tests were used to assess
184
differences between allocation groups.
185
Treatment effectiveness of the two interventions (midfoot joint mobilization, sham) on
186
pain in the past week and pre-and post-intervention patient-reported outcomes measures was
187
compared using dependent t-tests. Proportion estimates and 95% CI were calculated for
188
dichotomous variables. The effects of treatment (midfoot joint mobilization, sham) and time
189
(immediate change, pre-to-1-week change) on clinical measures were assessed using within-
190
subjects repeated measures ANOVAs. Change scores that had a 95% CI that did not cross zero
191
were considered to represent a significant change. Significant changes in outcomes observed
192
immediate post-treatment that were non-significant pre-to-1-week were interpreted as having an
193
immediate, but fleeting effect. Ordinal measures that had greater than five items (GROC) were
194
treated as continuous data during analysis.42,45 Participants were analyzed per allocation using
195
intention to treat.
196
Post hoc Cohen’s d effect size (ES) point estimates and 95% CI8 comparing treatments
197
were calculated for all significant treatment or treatment by time interactions for immediate pre-
198
to-post and 1-week change scores. ES 0-0.19 were interpreted as trivial, 0.2-0.49 small, 0.5-0.79
199
moderate, and >0.8 large.8
200
Data was analyzed using Statistical Package for Social Sciences (SPSS) Version 23.0
201
(IBM, Inc., Armonk, New York) and Microsoft Excel for Mac 2016 (Microsoft Corp., Redmond,
202
WA). The level of significance was p ≤.05 for all analyses.
203 204
RESULTS
205 206
There were no statistical differences in demographics, injury history, foot posture, or
207
patient-reported outcome measures between allocation groups at initial baseline, with the
208
exception of idFAI (Table 1). The group allocated to receive the sham intervention first had
209
significantly greater self-reported instability (IdFAI=26.6±3.5) compared to the joint
210
mobilization first group (IdFAI= 20.7±4.6, p=.009). Objective physical measures were similar
211
between groups prior to treatment. (Tables 3-5). In the assessment of carryover effects between
212
baselines 1 and 2, rearfoot inversion motion was the only measure that had a significant
213
treatment by order interaction.
214
Midfoot inversion and 1st tarsometatarsal plantar hypomobility were present in all
215
participants. Thus, all participants were eligible for random allocation. Joint cavitation was
216
experienced by 35.3% of participants during forefoot mobilization and none during
217
tarsometatarsal mobilization. Between allocation groups, 85.7% of the first mobilization group
218
and 83.3% of the second mobilization group participants received a second 30 second bout of
219
forefoot mobilizations. All participants received a second bout of tarsometatarsal mobilizations.
220
No participants who received the second bout of mobilizations experienced a cavitation in either
221
the midfoot or forefoot.
222
Self-reported compliance with the HEP on initial and final follow-up was 56.3±29.9%
223
and 65.4±21.6% in the initial sham allocation group and 74.5±16.1% and 60.6±31.9% in the
224
initial joint mobilization group, respectively. Seventy-five percent of the sham allocation group
225
was able to appropriately demonstrate the HEP following the first and second weeks. The
226
proportion of the mobilization group able to demonstrate the HEP was 62.5±31.9% during the
227
first week and 87.5±34.6% during the second week.
228
PATIENT-REPORTED OUTCOME MEASURES
229
Between the initial and follow-up visits, there were significant pre to 1-week post
230
improvements reported by both allocation groups in PROMIS physical health composite score,
231
FAAM-ADL (score and SANE), FAAM-Sport (score and SANE), and worst pain in the past
232
week. Only the mobilization treatment had a small, but significant decrease in PROMIS mental
233
health composite score. There were no other significant changes in patient-reported outcomes
234
following the first week of the trial.
235
Between the follow-up to final visits, both allocation groups reported significant
236
improvements in Godin leisure activity, FAAM-ADL score, FAAM-Sport (score and SANE),
237
and worst pain in the past week. Only the sham treatment had improvement in PROMIS physical
238
and mental health composite scores. There were no further changes resulting from either
239
treatment during the second week of the trial.
240
There was significantly greater perceived improvement immediately following joint
241
mobilization as compared to the sham treatment (SANE: p=.04, d=0.6, 95% CI: -0.1, 1.3;
242
GROC: p=.05, d =0.6, 95% CI: -0.1, 1.3) that lasted to 1-week following treatment (SANE:
243
p<.001 GROC: p<.001). A greater reduction in pain was observed following joint mobilizations
244
at 1-week following treatment (p=.004, d =-0.8, 95% CI: -1.5, -0.1). There were no significant
245
differences between treatments for pain at present (p=.10) or worst in the past week (p=.10).
246
Both treatments resulted in a significant decrease in kinesiophobia following the 2-week trial
247
(mean change=-3.1±2.6, p<.001, d=0.8, 95% CI: 0.1, 1.3). While there were no other significant
248
differences between treatments immediate post or 1-week following intervention, group means
249
improved as a result of both treatments resulting in improvements that exceeded minimal
250
clinically important differences in function.36 Table 2 details the comparison of treatment on
251
change in patient-reported outcome measures. Effect size estimates and 95% CI are in Figure 5.
252 253
PHYSICAL OUTCOME MEASURES
254
Pre-intervention descriptive statistics for both allocation groups at Baselines 1 and 2 are
255
in Tables 3-5. Immediate post-intervention and 1-week mean change scores and 95% CI for the
256
joint mobilization and sham treatments are in Figures 3-4. Effect size estimates and 95% CI are
257
in Figure 5.
258 259
Foot Morphology There was a significant increase in arch height flexibility immediate post-mobilization,
260
but not at 1-week post-treatment. There were no further significant changes post-intervention
261
changes immediately or 1-week following and no treatment, time, or treatment by time
262
interactions for foot morphologic composite measures (Table 3).
263
Ligament Pain-to-Palpation
264
There were no statistically significant differences pre-to-post intervention or between
265
treatments for proportion of participants with syndesmotic, bifurcate, anterior talofibular,
266
calcaneofibular, or posterior talofibular pain-to-palpation (Table 3).
267
Joint Motion
268
In the rearfoot, there were significant immediate pre-to-post increases in WBDF and
269
plantarflexion motion, with persistent improvements in WBDF observed at 1-week post-
270
treatment in both groups (Figure 3). In the forefoot, there was a significant increase in forefoot
271
inversion motion and frontal plane excursion motion immediate post sham intervention, but not
272
at 1-week post. First tarsometatarsal excursion significantly increased immediately following
273
joint mobilization (Figure 5). There were no other significant findings for any rearfoot or
274
forefoot joint motion measures (Figure 3-4).
275
Strength and Dynamic Balance
276
A small, but significant decrease in normalized dorsiflexion strength was observed
277
immediately post-intervention for the joint mobilization treatment only. There were no other
278
significant differences for strength measures (Figure 5).
279 280
For dynamic balance measures, there was a significant time effect for improved normalized SEBT composite scores (p<.001), but no other significant findings (Figure 5).
281 282
DISCUSSION
283 284
The principal findings of this crossover clinical trial were that midfoot joint mobilization
285
and a HEP consisting of stretching, strengthening, and balance had greater effects in reducing
286
pain, perceived improvement, and rearfoot, midfoot, and forefoot joint motion as compared to a
287
combined sham treatment and HEP. Regardless of treatment, participants experienced reduction
288
of worst pain in the past week and improvement in self-reported physical activity, function,
289
kinesiophobia, and SEBT performance post-treatment.
290
Both groups had substantial self-reported pain, instability, and activity limitation at
291
baseline that improved with time and treatment. In a unique case-study detailing pre-to-post
292
changes in patient reported outcomes following a LAS, substantial changes in perceived
293
instability, function, and kinesiophobia are observed following injury.14 Due to the abbreviated
294
epoch utilized in the previous case and in the current study, it is unclear if these participants will
295
progress to develop CAI in the long-term.
296
The mechanism of effectiveness of manual therapy is complex and may result in psycho-
297
emotional, neurophysiologic, and mechanical effects.4 Together, these effects may facilitate
298
functional restoration following LAS. For this reason, we opted to collect multidimensional
299
outcome measures to capture potential clinical improvements in body structure and function,
300
activity limitation, and participation restriction that may have resulted from the intervention.
301
Specific effects encompassed in the three domains include pain rating, expectations,
302
psychological measures, and neuromotor response.4 Our findings support that midfoot joint
303
mobilization, when combined with a HEP, may help to improve impairment in these domains
304
and facilitate resumption of activity.
305
Pain reduction was achieved immediately and 1-week following joint mobilization, a
306
finding that can be contextualized using the minimal important differences (MID). Landorf and
307
colleagues33
308
scale. In our study, only the joint mobilization treatment exceeded this MID at 1-week post
309
intervention. Both treatments reduced severity of pain at its worst that exceeded the MID. There
310
was also improved function in the FAAM-ADL and Sport that exceeded minimal detectable
311
change and minimal clinically important differences following the two treatments.36
312
reported that the average MID for foot conditions to be 0.8cm on the VAS pain
We observed positive psychological effects following joint mobilization intervention.
313
Perceived improvement was significantly higher following joint mobilization compared to sham.
314
Psychological traits such as high resiliency and self-efficacy have been suggested to have an
315
important role in injury recovery and return to sport.9,37 While long-term effects of joint
316
mobilization are unclear from our findings, we anticipate that earlier improvements in perceived
317
pain and recovery will create greater optimism and personal investment into treatment that may
318
influence long-term outcomes. Since kinesiophobia is a predictor for disability in patients with
319
foot conditions,34 the significant decrease in this measure following both treatments was a good
320
prognostic indicator for favorable outcomes.
321
A progressive increase in dynamic balance was observed following both treatments.
322
Following LAS, there is peripheral27,41 and central29,31 neurophysiologic consequences following
323
injury. Manual therapy has previously been shown to influence dynamic balance.24 It is unclear
324
from these data if improvements were a result of a neurophysiologic treatment effect, time and
325
healing, or from motor learning when performing a novel task. Ankle dorsiflexion is a covariate
326
with SEBT performance,2 a measure that also increased with time. Lastly, perceived
327
improvement following treatment may influence SEBT measures. Psychological factors, such as
328
previous psychological trauma, have been found be a salient factor in functional movement
329
performance to include the SEBT.48 It is plausible that positive psychological factors resulting
330
from treatment may manifest as improvements in physical performance.
331
CLINICAL RECOMMENDATIONS
332
Midfoot joint mobilizations are recommended, when clinically indicated, as part of a
333
multimodal treatment approach with LAS patients. Patients with midfoot hypomobility or a more
334
inverted rearfoot (with physiologic shift of the forefoot into eversion) may benefit from this
335
treatment.15 Significant clinical improvements were also observed in participants who received
336
the sham treatment and performed exercises that specifically addressed the midfoot and forefoot.
337
While we did not observe ideal compliance with the HEP, participants in both allocation groups
338
performed a substantial volume of exercise and demonstrated improvements with time. Inclusion
339
of stretching and strengthening exercises for the midfoot is recommended.
340
In practice, rehabilitation specialists should not provide treatment using a single
341
intervention approach. Our study design was chosen to evaluate treatment effects of midfoot
342
mobilization without potential confounding introduced by other clinician-provided treatments.
343
The standards of care dictate a comprehensive treatment plan that includes protection, optimal
344
loading, therapeutic exercise, sensorimotor training, and joint mobilization of the rearfoot and
345
shank.35 Coupled with a comprehensive treatment program that addresses rearfoot deficit,
346
midfoot joint mobilization may add value.
347
LIMITATIONS
348
A constraint of the crossover design is the potential for carryover effects. It is also
349
plausible that the order of intervention introduced bias. Participants allocated to receive the
350
mobilization during the second visit may have experienced clinical improvement resulting from
351
performance of the HEP, time, and healing. Similarly, significantly higher baseline
352
kinesiophobia observed in the group allocated to receive the sham treatment first could have
353
potentially mediated treatment outcomes. Comfort may be taken with knowledge that none of
354
our primary outcomes had significant time by order or treatment by order interactions. Also, the
355
decision to use change scores was made a priori to mitigate carryover effects following a one-
356
week washout period. The experimental treatment intervention included only a single session
357
midfoot mobilization and a 1-week HEP. Further research is needed to investigate midfoot
358
mobilization as part of a comprehensive ankle rehabilitation program of longer duration and
359
increased frequency. We utilized recreationally active young adults in our study, which limits the
360
generalizability of our findings to other populations. We included any participant with a recent
361
LAS regardless of number of previous sprains. Participants with both first-time LAS and acute-
362
on-chronic injuries were included. While this may have improved external validity, it is unclear
363
how this affected treatment responsiveness. Since this is the first study to our knowledge to study
364
the effects of a mobilization of the foot following LAS, it possible that the sample size was
365
inadequate to demonstrate significant effects in many of the study outcomes. Replication with a
366
larger sample is warranted. Lastly, we employed a wide range of outcomes to capture potential
367
improvements in clinical and patient-reported measures of physical and psychological
368
impairment, activity limitation, participation restriction, and personal factors that mediate
369
functional outcomes. That, in addition to the multiple potential mechanisms of effectiveness
370
theorized to result from MT,4 warranted investigation. This decision, while deliberate, may have
371
increased risk of a Type I error. While this is a potential outcome when performing multiple
372
comparisons, the authors did not rely on p-values alone and factored ES estimates when forming
373
conclusions.
374 375
CONCLUSION
376 377
Midfoot joint mobilization and a HEP consisting of stretching, strengthening, and
378
balance had greater effects in reducing pain and increasing perceived improvement as compared
379
to a combined sham treatment and HEP. Regardless of treatment, participants had reduced
380
severity of pain in the week previous and improvement in self-reported physical activity,
381
function, kinesiophobia, and SEBT performance. This improvement is likely partly attributed to
382
the effects of the HEP and healing. Midfoot joint mobilizations, stretching, and strengthening
383
exercises are recommended as part of a comprehensive rehabilitation program in LAS patients
384
with midfoot hypomobility or a more inverted rearfoot.
385
386
REFERENCES
387 388
1. Agnholt J, Nielsen S, Christensen H. Lesion of the ligamentum bifurcatum in ankle sprain. Arch Orthop Trauma Surg. 1988;107(5):326-328. doi:10.1007/BF00451515.
389 390 391
2. Basnett CR, Hanish MJ, Wheeler TJ, et al. Ankle dorsiflexion range of motion influences dynamic balance in individuals with chronic ankle instability. Int J Sports Phys Ther. 2013;8(2):121-128.
392 393 394
3. Bennell K, Talbot R, Wajswelner H, Techovanich W, Kelly D, Hall A. Intra-rater and interrater reliability of a weight-bearing lunge measure of ankle dorsiflexion. Aust J Physiother. 1998;44(3):175-180. doi:10.1016/S0004-9514(14)60377-9.
395 396 397
4. Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The Mechanisms of Manual Therapy in the Treatment of Musculoskeletal Pain: A Comprehensive Model. Man Ther. 2009;14(5):531-538. doi:10.1016/j.math.2008.09.001.
398 399
5. Blakeslee TJ, Morris JL. Cuboid syndrome and the significance of midtarsal joint stability. J Am Podiatr Med Assoc. 1987;77(12):638-642. doi:10.7547/87507315-77-12-638.
400 401 402
6. Cameron KL, Owens BD, DeBerardino TM. Incidence of ankle sprains among active-duty members of the United States Armed Services from 1998 through 2006. J Athl Train. 2010;45(1):29-38. doi:10.4085/1062-6050-45.1.29.
403 404
7. Carcia CR, Martin RL, Drouin JM. Validity of the Foot and Ankle Ability Measure in Athletes With Chronic Ankle Instability. J Athl Train. 2008;43(2):179-183.
405
8. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Academic Press; 2013.
406 407
9. Connolly FR, Aitken LM, Tower M. An integrative review of self-efficacy and patient recovery post acute injury. J Adv Nurs. 2014;70(4):714-728. doi:10.1111/jan.12237.
408 409 410
10. Delahunt E, Coughlan GF, Caulfield B, Nightingale EJ, Lin C-WC, Hiller CE. Inclusion criteria when investigating insufficiencies in chronic ankle instability: Med Sci Sports Exerc. 2010;42(11):2106-2121. doi:10.1249/MSS.0b013e3181de7a8a.
411 412 413
11. Doherty C, Bleakley C, Hertel J, Caulfield B, Ryan J, Delahunt E. Recovery from a first-time lateral ankle sprain and the predictors of chronic ankle instability: a prospective cohort analysis. Am J Sports Med. 2016;44(4):995-1003. doi:10.1177/0363546516628870.
414 415 416
12. Donahue M, Simon J, Docherty CL. Reliability and validity of a new questionnaire created to establish the presence of functional ankle instability: the IdFAI. Athl Train Sports Health Care. 2013;5(1):38-43. doi:10.3928/19425864-20121212-02.
417 418 419
13. Fraser JJ, Feger MA, Hertel J. Clinical commentary on midfoot and forefoot involvement in lateral ankle sprains and chronic ankle instability. part 2: clinical considerations. Int J Sports Phys Ther. 2016;11(7):1191-1203.
420 421
14. Fraser JJ, Hertel J. Preinjury to Postinjury Disablement and Recovery After a Lateral Ankle Sprain: A Case Report. J Athl Train. August 2018. doi:10.4085/1062-6050-114-17.
422 423 424
15. Fraser JJ, Koldenhoven RM, Jaffri AH, et al. Foot impairments contribute to functional limitation in individuals with ankle sprain and chronic ankle instability. Knee Surg Sports Traumatol Arthrosc. July 2018. doi:10.1007/s00167-018-5028-x.
425 426 427
16. Fraser JJ, Koldenhoven RM, Saliba SA, Hertel J. Reliability of ankle-foot morphology, mobility, strength, and motor performance measures. Int J Sports Phys Ther. 2017;12(7):1134-1149. doi:10.16603/ijspt20171134.
428 429
17. Godin G, Shephard RJ. Godin leisure-time exercise questionnaire. Med Sci Sports Exerc. 1997;29(6):36-38.
430 431 432
18. Golanó P, Vega J, Leeuw PAJ de, et al. Anatomy of the ankle ligaments: a pictorial essay. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):944-956. doi:10.1007/s00167-016-40594.
433 434
19. Greisberg J, Prince D, Sperber L. First ray mobility increase in patients with metatarsalgia. Foot Ankle Int. 2010;31(11):954-958. doi:10.3113/FAI.2010.0954.
435 436
20. Gribble PA, Hertel J. Considerations for normalizing measures of the star excursion balance test. Meas Phys Educ Exerc Sci. 2003;7(2):89-100. doi:10.1207/S15327841MPEE0702_3.
437 438 439 440 441
21. Hashimoto T, Sakuraba K. Assessment of effective ankle joint positioning in strength training for intrinsic foot flexor muscles: a comparison of intrinsic foot flexor muscle activity in a position intermediate to plantar and dorsiflexion with that in maximum plantar flexion using needle electromyography. J Phys Ther Sci. 2014;26(3):451-454. doi:10.1589/jpts.26.451.
442 443 444 445
22. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873-880. doi:10.1007/s11136-009-9496-9.
446 447 448
23. Hertel J, Braham RA, Hale SA, Olmsted-Kramer LC. Simplifying the star excursion balance test: analyses of subjects with and without chronic ankle instability. J Orthop Sports Phys Ther. 2006;36(3):131-137.
449 450 451
24. Hoch MC, Andreatta RD, Mullineaux DR, et al. Two-week joint mobilization intervention improves self-reported function, range of motion, and dynamic balance in those with chronic ankle instability. J Orthop Res. 2012;30(11):1798-1804. doi:10.1002/jor.22150.
452 453 454
25. Hølmer P, Søndergaard L, Konradsen L, Nielsen PT, Jørgensen LN. Epidemiology of Sprains in the Lateral Ankle and Foot. Foot Ankle Int. 1994;15(2):72-74. doi:10.1177/107110079401500204.
455 456
26. Hubbard TJ. Ligament laxity following inversion injury with and without chronic ankle instability. Foot Ankle Int. 2008;29(3):305-311. doi:10.3113/FAI.2008.0305.
457 458
27. Jazayeri Shooshtari SM, Didehdar D, Moghtaderi Esfahani AR. Tibial and peroneal nerve conduction studies in ankle sprain. Electromyogr Clin Neurophysiol. 2007;47(6):301-304.
459 460
28. Jennings J, Davies GJ. Treatment of cuboid syndrome secondary to lateral ankle sprains: a case series. J Orthop Sports Phys Ther. 2005;35(7):409–415.
461 462 463
29. Kim K-M, Ingersoll CD, Hertel J. Altered postural modulation of Hoffmann reflex in the soleus and fibularis longus associated with chronic ankle instability. J Electromyogr Kinesiol. 2012;22(6):997-1002. doi:10.1016/j.jelekin.2012.06.002.
464 465
30. Kinzey SJ, Armstrong CW. The reliability of the star-excursion test in assessing dynamic balance. J Orthop Sports Phys Ther. 1998;27(5):356–360.
466 467 468
31. Kosik KB, Terada M, Drinkard CP, Mccann RS, Gribble PA. Potential corticomotor plasticity in those with and without chronic ankle instability. Med Sci Sports Exerc. 2017;49(1):141-149. doi:10.1249/MSS.0000000000001066.
469 470
32. Kristianslund E, Bahr R, Krosshaug T. Kinematics and kinetics of an accidental lateral ankle sprain. J Biomech. 2011;44(14):2576-2578. doi:10.1016/j.jbiomech.2011.07.014.
471 472 473
33. Landorf KB, Radford JA, Hudson S. Minimal Important Difference (MID) of two commonly used outcome measures for foot problems. J Foot Ankle Res. 2010;3:7. doi:10.1186/17571146-3-7.
474 475 476
34. Lentz TA, Sutton Z, Greenberg S, Bishop MD. Pain-Related Fear Contributes to SelfReported Disability in Patients With Foot and Ankle Pathology. Arch Phys Med Rehabil. 2010;91(4):557-561. doi:10.1016/j.apmr.2009.12.010.
477 478 479 480 481
35. Martin RL, Davenport TE, Paulseth S, Wukich DK, Godges JJ. Ankle stability and movement coordination impairments: ankle ligament sprains: clinical practice guidelines linked to the international classification of functioning, disability and health from the orthopaedic section of the american physical therapy association. J Orthop Sports Phys Ther. 2013;43(9):A1-A40. doi:10.2519/jospt.2013.0305.
482 483
36. Martin RL, Irrgang JJ, Burdett RG, Conti SF, Van Swearingen JM. Evidence of validity for the foot and ankle ability measure (FAAM). Foot Ankle Int. 2005;26(11):968–983.
484 485
37. McCann RS, Gribble PA. Resilience and Self-Efficacy: A Theory-Based Model of Chronic Ankle Instability. Int J Athl Ther Train. 2016;21(3):32-37. doi:10.1123/ijatt.2015-0032.
486 487 488
38. McPoil TG, Vicenzino B, Cornwall MW, Collins N, Warren M. Reliability and normative values for the foot mobility magnitude: a composite measure of vertical and medial-lateral mobility of the midfoot. J Foot Ankle Res. 2009;2(1):6. doi:10.1186/1757-1146-2-6.
489 490 491
39. Moher D, Schulz KF, Altman D, Group C, others. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore J Sci Heal. 2005;1(1):40–45.
492 493
40. Mooney M, Maffey-Ward L. Cuboid plantar and dorsal subluxations: assessment and treatment. J Orthop Sports Phys Ther. 1994;20(4):220–226.
494 495
41. Nitz AJ, Dobner JJ, Kersey D. Nerve injury and grades II and III ankle sprains. Am J Sports Med. 1985;13(3):177-182.
496 497
42. Norman G. Likert scales, levels of measurement and the “laws” of statistics. Adv Health Sci Educ. 2010;15(5):625-632. doi:10.1007/s10459-010-9222-y.
498 499 500 501
43. Panagiotakis E, Mok K-M, Fong DT-P, Bull AMJ. Biomechanical analysis of ankle ligamentous sprain injury cases from televised basketball games: understanding when, how and why ligament failure occurs. J Sci Med Sport. 2017;20(12):1057-1061. doi:10.1016/j.jsams.2017.05.006.
502 503 504
44. Redmond AC, Crosbie J, Ouvrier RA. Development and validation of a novel rating system for scoring standing foot posture: The Foot Posture Index. Clin Biomech. 2006;21(1):89-98. doi:10.1016/j.clinbiomech.2005.08.002.
505 506 507 508
45. Rhemtulla M, Brosseau-Liard PÉ, Savalei V. When can categorical variables be treated as continuous? A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions. Psychol Methods. 2012;17(3):354-373. doi:10.1037/a0029315.
509 510 511
46. Roos KG, Kerr ZY, Mauntel TC, Djoko A, Dompier TP, Wikstrom EA. The epidemiology of lateral ligament complex ankle sprains in national collegiate athletic association sports. Am J Sports Med. 2017;45(1):201-209. doi:10.1177/0363546516660980.
512 513
47. Søndergaard L, Konradsen L, Hølmer P, Jørgensen LN, Nielsen PT. Acute midtarsal sprains: frequency and course of recovery. Foot Ankle Int. 1996;17(4):195-199.
514 515
48. Taylor MK, Hernández LM, Sessoms P, Kawamura C, Fraser JJ. Trauma exposure predicts functional movement characteristics of male tactical athletes. J Athl Train. In Press.
516 517
49. Waterman BR. The epidemiology of ankle sprains in the united states. J Bone Jt Surg Am. 2010;92(13):2279-2284. doi:10.2106/JBJS.I.01537.
518 519 520
50. Woby SR, Roach NK, Urmston M, Watson PJ. Psychometric properties of the TSK-11: A shortened version of the Tampa Scale for Kinesiophobia: Pain. 2005;117(1):137-144. doi:10.1016/j.pain.2005.05.029.
521 522 523 524
51. Zifchock RA, Theriot C, Hillstrom HJ, Song J, Neary M. The Relationship Between Arch Height and Arch Flexibility: A Proposed Arch Flexibility Classification System for the Description of Multi-Dimensional Foot Structure. J Am Podiatr Med Assoc. February 2017. doi:10.7547/15-051.
525 526
527 528 529 530 531 532 533 534 535 536 537
List of Tables Table 1. Demographic, injury history, and patient-reported outcome measures in individuals with ankle sprain Table 2. Comparison of treatment on change in patient-reported outcome measures in individuals with ankle sprain Table 3. Comparison of treatment on composite morphologic foot measurement and proportion with ligamentous pain-to-palpation in individuals with ankle sprain Table 4. Comparison of treatment on rearfoot and forefoot joint motion measurements in individuals with ankle sprain Table 5. Comparison of treatment on neuromotor function and dynamic balance in individuals with ankle sprain
538 539
List of Figures
540
Figure 1. CONSORT Flow Diagram.
541
Figure 2. Home exercise program. From XXXXXXXXXXXXXXXXXXXXXXXXX.
542
Used with permission of the publisher.
543
Figure 3. Rearfoot and forefoot joint motion change measures.
544
Figure 4. Strength and dynamic balance change measures.
545
Figure 5. Effect size estimates and 95% confidence intervals comparing joint
546
mobilization to sham treatment.
Table 1. Demographic, injury history, and patient-reported outcome measures in individuals with ankle sprain Participants Participants allocated Total Sample allocated to receive to receive midfoot sham intervention mobilization first (n=17) 8 males 9 females first (n=8) (n=9) 4 males 4 females 4 males 5 females Mean ± SD p Mean ± SD Age (years) 20.4±1.3 23.2±5.3 .17 21.0±2.3 Height (cm) 170.2±8.8 174.1±9.5 .39 172.3±2.2 Weight (kg) 67.1±13.5 75.7±10.6 .17 71.6±12.5 2 BMI (kg/m ) 23.1±3.4 25.0±3.9 .29 24.1±3.7 Foot Posture Index 2.0±3.6 3.0±3.2 .56 2.5±3.4 Ankle sprains (n) 2.5±1.4 3.2±3.0 .54 2.9±2.3 Time to injury (months) 0.9±0.5 0.9±0.7 .84 0.9±0.6 IdFAI 26.6±3.5 20.7±4.6 .009 23.9±4.7 Kinesiophobia (TSK-11) 23.9±4.7 20.4±4.3 .14 22.1±4.7 cm=centimeters, kg=kilograms, BMI=body mass index, IdFAI=Identification of Functional Ankle Instability, TSK=Tampa Scale Kinesiophobia
Table 2. Comparison of treatment on change in patient-reported outcome measures in individuals with ankle sprain Pre-to-Post Pre-to-Post Baseline 2 Change Change Mean±SD p Pain VAS (cm) IMM:0.3±1.8 IMM:0.4±0.6 Sham 1.4±1.5* 0.9±1.0† .10‡ At Present 1wk: -0.2±1.3 1wk: 0.4±0.6 .004§ IMM:-0.6±1.3 IMM:0.2±0.7 .08|| Treatment 2.0±2.1† 1.2±1.7* 1wk: -1.1±1.4 1wk: -0.8±1.7 Sham 3.5±1.9* -1.9±1.7 1.8±1.1† -0.7±1.3 Worst in the Past Week .10 † * Treatment 3.3±1.8 -1.6±1.6 1.6±1.8 -0.9±1.6 PROMIS General Health (t) Sham 49.2±5.8* 2.9±5.5 55.6±3.9† 2.4±6.7 .87 † * Physical Composite Treatment 52.0±6.8 2.4±6.7 52.0±6.0 1.8±5.9 Sham 55.9±7.0* 1.3±5.2 61.7±4.5† 3.1±2.1 Mental Composite .28 † Treatment 62.1±8.3 -2.8±3.0 57.1±11.0* 1.9±7.5 Sham 47.1±27.2* 3.5±13.5 84.3±101.4† 9.8±19.5 Godin Leisure Time Activity .32 † Treatment 42.8±24.7 39.5±92.7 50.6±19.0* 7.1±13.4 FAAM (%) Sham 74.0±17.1* 12.3±16.1 92.6±4.0† 2.0±3.9 .81 † ADL Score Treatment 78.7±13.3 12.0±10.5 86.3±9.4* 4.4±4.8 * † Sham 46.9±27.7 19.9±22.0 70.5±18.7 13.1±16.0 Sport Score .88 Treatment 46.6±31.4† 22.9±21.3 66.8±20.3* 10.8±11.3 IMM:4.0±12.7* IMM:10.0±31.3† Sham .04‡ 1wk: 35.7±34.1* 1wk: 65.0±29.8† Perceived Improvement <.001§ SANE (%) IMM:36.2±42.5† IMM:21.4±21.7* .27|| Treatment 1wk: 56.9±33.1† 1wk: 56.9±37.0* IMM:.63±2.0† IMM:-0.1±1.4* Sham .05‡ * 1wk: 2.0±1.9 1wk: 4.1±1.7† Global Rating of Change <.001§ IMM 2.4±2.6† IMM:1.4±2.3* .19|| Treatment 1wk: 3.1±2.0† 1wk: 3.9±2.4* IMM=Immediate pre-to-post change, 1wk=Pre-to-1-week post change, VAS = visual analogue scale, PROMIS=Patient Reported Outcome Measures Information System, FAAM=Foot and Ankle Ability Measure, ADL=activities of daily living, SANE=single assessment numeric evaluation *Received sham intervention first, †Received midfoot joint mobilization first ‡ Treatment Main Effect, § Time Main Effect, || Treatment by Time Interaction Baseline 1
Table 3. Comparison of treatment on composite morphologic foot measurement and proportion with ligamentous pain-to-palpation in individuals with ankle sprain Baseline 1 Baseline 2 Pre-to-Post Change p Composite Foot Measures (95% CI) Mean±SD IMM:0.0 (-0.3, 0.3) Sham 1.3±0.8* 1.5±0.8† Arch Height 26‡ 1-wk: 0.0 (-0.2, 0.2) Flexibility .88§ IMM:0.3 (0.1, 0.5) -1 (cm kg ) Treatment .91|| 1.2±0.4† 2.4±1.0* 1-wk: 0.2 (-0.1, 0.5) IMM:0.4 (-0.3, 1.1) * † Sham 1.9±1.5 3.5±3.0 .70‡ 1-wk: 0.2 (-0.7, 2.1) Foot Mobility .73§ Magnitude (cm) IMM:-0.2 (-0.6, 1.0) † * .60|| Treatment 3.4±1.7 3.4±0.7 1-wk: 0.2 (-0.8, 1.2) Proportion Pre-to-Post Change Ligamentous Pain-to-Palpation (95% CI) (95% CI) * † Anterior talofibular Sham 50.0 (21.5, 78.5) 25.0 (7.1, 59.1) -17.7 (-44.1, 12.0) ligament (%) Treatment 22.2 (6.3, 54.7) † 12.5 (2.2, 47.1) * 7.7 (-21.4, 35.8) Calcaneofibular Sham 12.5 (2.2, 47.1) * 12.5 (2.2, 47.1) † -5.8 (-30.0, 19.0) Treatment 33.3 (12.1, 64.6) † 12.5 (2.2, 47.1) * -11.0 (-36.4, 16.3) ligament (%) * † -6.2 (-31.4, 20.0) Sham 12.5 (2.2, 47.1) 12.5 (2.2, 47.1) Bifurcate ligament † * (%) -4.3 (-29.6, 22.8) Treatment 22.2 (6.3, 54.7) 0.0 (0.0, 32.4) cm=centimeters, kg=kilograms, IMM=immediate, wk=week *Received sham intervention first, †Received midfoot joint mobilization first ‡ Treatment Main Effect, § Time Main Effect, || Treatment by Time Interaction
Table 4. Comparison of treatment on rearfoot and forefoot joint motion measurements in individuals with ankle sprain Baseline 1 Baseline 2 Rearfoot Mean±SD Weight-bearing Sham 9.8±3.2 * 9.7±2.6† † Dorsiflexion (cm) Treatment 12.0±7.8 11.0±3.0 * Sham 67.5±9.7 * 58.9±8.4† † Plantarflexion (º) Treatment 60.8±6.5 66.9±10.1 * Sham 31.3±9.2 * 35.4±9.5† Inversion (º) † Treatment 34.0±7.8 30.4±8.7 * Sham 11.1±5.4 * 12.6±4.1† Eversion (º) † Treatment 13.9±5.6 10.8±4.8 * Forefoot Inversion (º) Eversion (º) 1st Metatarsal Dorsiflexion (mm)
Sham Treatment Sham Treatment
32.9±7.9 * 36.2±9.8 † 17.7±5.2 * 20.5±9.5 †
42.8±7.8 † 32.8±7.3 * 18.0±6.9 † 16.5±4.6 *
Sham 5.3±1.5 * 5.8±1.1 † † Treatment 5.7±1.9 5.0±1.6 * Plantarflexion (mm) Sham 6.8±2.1 * 7.7±1.3 † † Treatment 8.0±1.4 6.9±1.8 * *Received sham intervention first, †Received midfoot joint mobilization first
Table 5. Comparison of treatment on neuromotor function and dynamic balance in individuals with ankle sprain Baseline 1 -1
Strength (normalized, Nm kg ) Ankle Dorsiflexion Ankle Plantarflexion Ankle Inversion Ankle Eversion Hallux Flexion Lesser Toe Flexion
Baseline 2
Mean±SD Sham Treatment Sham Treatment Sham Treatment Sham Treatment Sham Treatment Sham Treatment
*
3.1±0.8 3.2±0.9 † 5.2±1.4 * 5.5±2.8 † 2.3±0.6 * 2.0±0.6 † 2.2±0.6 * 2.2±0.6 † 0.9±0.2 * 0.6±0.2 † 0.8±0.2 * 0.6±0.2 †
3.1±1.4 † 3.2±0.7 * 5.2±3.6 † 5.6±1.5 * 1.9±1.0 † 2.5±0.6 * 2.1±1.1 † 2.3±0.6 * 0.6±0.3 † 1.0±0.2* 0.6±0.3 † 0.9±0.1 *
Dynamic Balance (normalized, %) Sham 68.9±5.2 * 73.8±3.9 † † Treatment 70.4±5.0 77.0±4.6 * SEBT = Star Excursion Balance Test *Received sham intervention first, †Received midfoot joint mobilization first Composite SEBT
Highlights • • •
A trial was performed assessing midfoot joint mobilization after ankle sprain vs. sham Midfoot joint mobilizations yielded greater pain reduction and perceived improvement Midfoot joint mobilizations are recommended with exercises following ankle sprain.